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Objective: The aim of this study was to describe our experience with the diagnosis and management of
acquired uterine vascular abnormalities associated with persistent human chorionic gonadotropin (hCG).
Through this case series, we sought to establish our protocol for the treatment and follow-up of uterine
vascular lesions associated with persistent hCG.
Materials and methods: We examined the clinical presentations of 28 Korean women with acquired
vascular uterine abnormalities associated with persistent hCG who were seen in the Department of
Obstetrics and Gynecology of the Gangneung Asan Teaching Hospital, Gangneung-si, Korea between
October 2006 and July 2012 and retrospectively reviewed their medical records.
Results: The mean patient age was 32.5 ± 6.4 years, and the mean parity was 1.4 ± 1.2. The mean size of
the vascular lesions in color Doppler sonography and multidetector computed tomography with angi-
ography was 3.1 ± 1.6 cm and 3.9 ± 1.6 cm, respectively. Multidetector computed tomography revealed
arteriovenous malformation-like vascular lesions (n ¼ 15) and pseudoaneurysms (n ¼ 3). Treatments
included clinical observation (n ¼ 11), uterine artery embolization (n ¼ 11), hysterectomy (n ¼ 4), and
chemotherapy, including single methotrexate (MTX) treatment and combination chemotherapy (n ¼ 9).
Conclusion: When the uterine vascular lesion is not decreased, or if weekly clinical follow-up reveals that
the serum b-hCG level is persistently elevated or sustained in conjunction with vaginal hemorrhage, a
proper management strategy is required.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Uterine vascular abnormalities are rare clinical ﬁndings.
Consequently, only a few cases of uterine vascular abnormalities
have been reported in the literature. Because these vascular lesions
were often overlooked by obstetricians and gynecologists and a
standard protocol for diagnosis and therapy has not yet been
established, there are difﬁculties associated with the diagnosis and
treatment of uterine vascular lesions [1].
Vascular abnormalities that affect the uterine arteries include
congenital arteriovenous malformations (AVMs), acquired AVMs,
arteriovenous ﬁstulas, true aneurysms, and pseudoaneurysms [2].and Gynecology, Gangneung
, 415, Bangdong-ri, Sacheon-
orea.
bstetrics & Gynecology. PublishedCongenital uterine AVMs are rare lesions resulting from the
abnormal embryonic development of primitive vascular structures
that cause abnormal communications between arteries and veins
[3]. We have encountered no cases of congenital AVM at our
institution. Congenital AVMs usually havemultiple feeding arteries,
a tangle of vessels with histological characteristics of both arteries
and veins, and many large draining veins [4]. Acquired uterine
AVMs typically result from trauma, such as a prior dilation and
curettage, a therapeutic abortion, uterine surgery, or direct uterine
trauma [5,6]. Endometrial carcinoma, cervical carcinoma, and
gestational trophoblastic diseases are other possible causes of ac-
quired uterine AVMs [7,8]. If a hypervascular lesion with typical
early venous ﬁlling within the myometrium is accompanied by a
negative serum b-hCG level, a uterine AVM diagnosis should be
considered [9]. However, uterine hypervascular lesions with tur-
bulent ﬂow have been observed with an elevated serum b-hCG
level in patients with gestational trophoblastic disease (GTD) andby Elsevier Taiwan LLC. All rights reserved.
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normalities with elevated serum b-hCG levels may be distinguished
from acquired AVM and associated with GTD and RPOC. However,
there are some difﬁculties associatedwith the pathologic diagnoses
of these lesions due to the limited availability of surgical specimens.
Therefore, the lesions with elevated serum b-hCG could be
considered to be acquired uterine vascular abnormalities associated
with persistent hCG and distinguished from AVM.
The most important clinical manifestation of uterine vascular
abnormalities is recurrent and/or profuse vaginal bleeding, which
may result in hypovolemic shock and/or death. Vaginal bleeding
arising from these vascular abnormalities may be aggravated by
dilation and curettage performed for the purpose of biopsy and
bleeding control, unlike excessive uterine bleeding due to other
common causes [6].
The management of these vascular lesions ranges from a con-
servative approach, such as observation or medication, to invasive
procedures, such as uterine artery embolization or emergency
hysterectomy. However, most reports in the literature consist of
only a few cases, and experience with vascular abnormalities at
individual institutions is limited. In this study, we present the im-
age patterns of uterine vascular abnormalities associated with
persistent hCG using sonography with color Doppler and multi-
detector computed tomography with angiography and describe our
ﬁndings regarding the immediate results and long-term outcomes
of these lesions. By examining this case series, we sought to
establish our protocol for the treatment and follow-up of uterine
vascular lesions associated with persistent hCG.
Materials and methods
This study was approved by Gangneung Asan Hospital Institu-
tional Research Ethics Committee (2010-056). We reviewed the
medical records of patients with acquired uterine vascular abnor-
malities associated with persistent hCG diagnosed and treated at
Gangneung Asan Hospital, Gangneung-si, Korea between October
2006 and July 2012. During the study period, a total of 3947 preg-
nancies, including abnormal pregnancies, were diagnosed at our
outpatient department. At our institution, uterine vascular abnor-
malities associatedwithpersistenthCGwerediagnosed in28patients
(0.71%). In this case series, patients with intrauterine vascular ab-
normalities with elevated serum b-hCG measurements were
enrolled. According to our study design, patients with normal intra-
uterine pregnancy or ectopic pregnancy, in addition to those with
uterine vascular lesions associated with negative serum b-hCG mea-
surements, would be excluded from the case series because serum b-
hCG measurements are elevated or sustained in normal intrauterine
pregnancy and ectopic pregnancy regardless of the presence of
uterine vascular abnormalities. Additionally, in cases of normal in-
trauterine pregnancy, multidetector computed tomography with
angiography shouldbeavoideddue to the radiationhazard associated
with this technique. For these reasons, we planned to exclude the
cases of normal intrauterine pregnancy with uterine vascular abnor-
malities. However, there were no cases of uterine vascular abnor-
malities with normal intrauterine pregnancy or ectopic pregnancy.
When patients with vaginal spotting or bleeding and whose
vital signs were stable visited our outpatient division, physical
examinations including a vaginal examination, urine hCG test, and
pelvic sonography with color Doppler were performed to detect
uterine abnormalities. Three cases without symptoms were
observed by chance during routine gynecological examinations. For
suspected uterine vascular lesions, we performed serial serum b-
hCG measurements and transvaginal sonography of the intrauter-
ine cavity to rule out a normal intrauterine pregnancy or an ectopic
pregnancy by additional image evaluation. In patients with stablevital signs, multidetector computed tomography with angiography
was performed to evaluate the uterine vascular lesions.
The management options for these uterine vascular abnormal-
ities consisted of observation, single chemotherapy with metho-
trexate (MTX), combination chemotherapy (EMA or EMA-CO),
transcatheter uterine artery embolization, and hysterectomy. At our
institution, the protocol for the treatment and follow-up of vascular
abnormalities was established based on clinical case series and case
reports in the literature (Figure 1). Based on our protocol for treat-
ment and follow-up, if there was profuse vaginal hemorrhage with
stable vital signs, transcatheter uterine artery embolization was
performed. If the patients had unstable vital signs because of profuse
vaginal bleeding, an emergency hysterectomy was performed. In
cases with vaginal spotting or no speciﬁc symptoms, clinical follow-
up, including transvaginal sonography with color Doppler and
serum b-hCG measurements, was performed weekly. For cases in
which two or three consecutive clinical follow-ups demonstrated a
sustained or elevated level of serum b-hCG, chemotherapy was
considered. For cases inwhich the size of the uterine vascular lesions
increased or failed to regress during clinical follow-up, a trans-
catheter uterine artery embolization was performed. After treat-
ment, we performed periodic physical examinations and measured
the patients' serum b-hCG levels in the outpatient division to check
for the recurrence of uterine vascular abnormalities.
Data are expressed as mean ± standard deviation (SD) unless
stated otherwise. All statistical analyses were performed with SPSS
version 13.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
The mean patient age was 32.5 ± 6.4 years (range, 19e42 years),
and the mean parity was 1.4 ± 1.2 (range, 0e4). Twenty-ﬁve pa-
tients had vaginal hemorrhage, two patients had no speciﬁc
symptoms, and one patient had amenorrhea. Regarding surgical
history, nine patients had undergone a cesarean section one or
more times, one patient had undergone an appendectomy, and one
patient had undergone laparoscopy.
The antecedent pregnancy events of the patients were the
following: missed abortion (n ¼ 11), intrauterine curettage for
artiﬁcial abortion (n ¼ 8), hydatidiform mole (n ¼ 5), cesarean scar
pregnancy (n ¼ 2), and unknown event (n ¼ 2). With these ante-
cedent pregnancy events, the patients had undergone surgical
procedures such as dilation and curettage (n ¼ 18), suction and
curettage (n ¼ 5), no procedure (n ¼ 3), MTX injection (n ¼ 1), and
unknown (n ¼ 1) before acquired uterine vascular abnormality was
diagnosed. In two patients, uterine vascular lesions were diagnosed
during a missed abortion (Figure 2).
The interval from the antecedent pregnancy event to the diag-
nosis of an acquired uterine vascular lesion ranged from 0 days to
192 days (mean ± SD: 48.9 ± 41.5 days). All patients had an elevated
serum b-hCG level at the time of diagnosis, and the mean serum b-
hCG level was 4,136.0 ± 10,399.9 mIU/mL, with a range from 3.9
mIU/mL to 48,427.0 mIU/mL. Therefore, we classiﬁed these lesions
as acquired uterine vascular abnormalities associated with preg-
nancy because the serum b-hCG level is not elevated in uterine
AVMs. A gray-scale transvaginal sonography with color Doppler
scan was performed in 27 patients, and one patient underwent an
emergency hysterectomy without a color Doppler scan because of
unstable vital signs. Color Doppler sonography of the vascular le-
sions revealed a high-ﬂow vascular lesion or tangles of vessels with
multidirectional high velocity ﬂow producing a color mosaic
pattern. In 22 of 27 patients, multidetector computed tomography
with angiography was performed. In ﬁve cases, uterine vascular
lesions were diagnosed with color Doppler sonography without
multidetector computed tomography.
Figure 1. Protocol for the treatment and follow-up of uterine vascular lesions at our institute.
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without an imaging study because of profuse vaginal hemorrhage
and unstable vital signs. The pathological diagnosis of the patient
was conﬁrmed as a uterine vascular lesion with an elevated serum
b-hCG level, and the patient was enrolled in the case series.
Based on the multidetector computed tomography images, the
vascular patterns of the lesions could be subdivided into AVM-like
vascular lesions (n ¼ 15) and pseudoaneurysms (n ¼ 7; Figure 3).
The mean size of the vascular lesions on color Doppler sonog-
raphy and multidetector computed tomography with angiography
were 3.1 ± 1.6 cm (range, 1.5e8.0 cm) and 3.9 ± 1.6 cm (range,
1.5e6.5 cm), respectively.
With regard to the management of the patients, nine patients
were placed under clinical observation. A uterine artery emboli-
zation was performed in ﬁve patients, and uterine arteryFigure 2. Color Doppler imaging of an arteriovenous malformation-like vascular lesion in a u
reveals (A) a tangle of vessels with multidirectional high-velocity ﬂow producing a color mo
In this case, massive vaginal hemorrhage during dilatation and curettage was expected, buembolization and chemotherapy, including single MTX and com-
bination chemotherapy, was prescribed for four patients. A hys-
terectomy was performed in four patients. Chemotherapy alone,
including single MTX and combination chemotherapy without any
other intervention, was prescribed as a treatment for two patients.
Following clinical observation and management, the uterine
vascular lesions disappeared in 25 patients, and three patients were
lost to follow-up (Figure 4).
Spontaneous regression of the vascular lesions was observed in
nine patients without medical or surgical treatment. The mean size
of the vascular lesions on color Doppler sonography in the spon-
taneous regression group was 2.4 ± 0.7 cm (range, 1.5e6.5 cm), and
the mean serum b-hCG levels at diagnosis was 3371.9 ± 9041.7
mIU/mL (range, 4.0e27,410.0 mIU/mL). Serum b-hCG levels spon-
taneously returned to a normal level in all of these patients, and theterus with a missed abortion. A sagittal transvaginal color Doppler image of the uterus
saic pattern and (B) persistent vascular lesion of the uterus after dilation and curettage.
t vaginal bleeding was minimal. Thereafter, additional treatment was not required.
Figure 3. The volume-rendering multidetector CT image shows an arteriovenous
malformation-like uterine vascular lesion feeding from the bilateral uterine arteries
and right ovarian artery.
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diagnosis was 42.9 ± 33.8 days (range, 7e120 days). The regression
time for vascular lesions was 48.8 ± 37.5 days (range, 1e132 days).
These results suggest that vascular lesions tend to persist after
serum b-hCG level normalization in cases of spontaneous
regression.
A uterine artery embolization was performed in ﬁve patients
(Figure 5). The mean sizes of the vascular lesions on color Doppler
sonography and multidetector computed tomography with angi-
ography were 3.0 ± 1.1 cm (range, 2.0e4.9 cm) and 3.3 ± 1.3 cm
(range, 2.0e5.6 cm), respectively. Despite the small lesion size
(2 cm), the patient with a pseudoaneurysm had profuse vaginal
hemorrhaging, and an emergent uterine artery embolization was
performed.Figure 4. Management for our case series of acquired uterine vascular abnBoth uterine artery embolization and chemotherapy were per-
formed in four patients. The mean size of the vascular lesions on
color Doppler sonography and multidetector computed tomogra-
phy with angiography were 3.4 ± 1.5 cm (range, 2.0e4.9 cm) and
4.6 ± 1.3 cm (range, 3.5e6.2 cm), respectively. The mean serum b-
hCG level at diagnosis was 4972.0 ± 6636.4 mIU/mL (range,
3.9e14,261.0 mIU/mL). After treatment, the serum b-hCG levels
returned to normal in all of these patients, and the mean time to
normalization after lesion diagnosis was 62.5 ± 12.6 days (range,
48e74 days).
A hysterectomy was performed in four patients. Emergency
hysterectomies were performed in two patients due to profuse
vaginal bleeding with unstable vital signs. One patient was trans-
ferred to the emergency unit because of profuse vaginal hemor-
rhaging with unstable vital signs. Another patient underwent an
emergency hysterectomy because of profuse vaginal hemorrhage
after a diagnostic endometrial biopsy in a surgical setting. The other
two patients underwent a hysterectomy because of treatment
failure after single MTX chemotherapy and/or uterine artery
embolization.
A pathological diagnosis of vascular lesions was conﬁrmed in
seven of the enrolled cases after a hysterectomy (n ¼ 4) or dilation
and curettage (n ¼ 3). In the dilation and curettage cases, two pa-
tients had a missed abortion with uterine vascular lesions. Fortu-
nately, no vaginal hemorrhage occurred after the dilation and
curettage in either case. In the third patient, dilation and curettage
was performed because of the presence of an intrauterine mass
after uterine artery embolization. The pathological diagnoses were
remnant conceptual tissues (n ¼ 4), products of conception (n ¼ 1),
invasive mole (n ¼ 1), and products of conception with hydropic
villi (n¼ 1). Pathological diagnoseswere not performed in the other
21 patients.ormalities associated with persistent human chorionic gonadotropin.
Figure 5. A selective internal iliac artery angiogram demonstrates (A) a uterine vascular abnormality associated with an arteriovenous malformation-like lesion, and (B) an aor-
togram after uterine arterial embolization with both coil and Gelfoam reveals complete obstruction of the vascular lesion.
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exception of the three patients for whom follow-up was not
continued. During the clinical follow-up, the vascular lesions did
not recur. A normal intrauterine pregnancy after management was
conﬁrmed in two cases that had been treated with uterine artery
embolizations. Severe preeclampsia was diagnosed in one patient
at a gestational age of 36 weeks and 5 days and who delivered a
female infant weighing 2.48 kg via an emergency cesarean section.
A histological examination of the placenta conﬁrmed the diagnosis
of a placental lake [11]. The second patient had fetal growth re-
striction at a gestational age of 38 weeks and 5 days. A male infant
weighing 2.23 kg was delivered via an uneventful vaginal delivery
after labor induction.
Discussion
Uterine vascular abnormalities are a rare gynecological condi-
tion; therefore, only a few cases have been reported in the litera-
ture. Vascular abnormalities that affect the uterine arteries include
congenital arteriovenous malformations (AVMs), acquired AVMs,
arteriovenous ﬁstulas, true aneurysms, and pseudoaneurysms. A
pseudoaneurysm is a contained rupture of an artery wall that arises
from disruption of the wall caused by inﬂammation, vascular
trauma, or iatrogenic injury, such as a surgical procedure, percu-
taneous biopsy, or drainage [12]. It has been reported that pseu-
doaneurysms of the uterine artery can be caused by cesarean
sections, dilation and curettage, hysterectomies, myomectomies,
oocyte retrieval for in vitro fertilization, and even uncomplicated
vaginal deliveries [13]. Although pseudoaneurysms of the uterine
artery can arise from traumatic causes, such as surgical procedures
of the uterus, a pseudoaneurysm rupture at the fundal area of the
uterus after cesarean delivery was reported in one study [14]. In
this case, it can be assumed that placental tissues played some role
in the disruption of the arterial wall.
Uterine AVMs are classiﬁed as congenital or acquired [15]. Ac-
quired uterine AVMs tend to result from trauma, such as prior
dilation and curettage, a therapeutic abortion, uterine surgery, or
direct uterine trauma [5e8]. Histopathological investigations have
demonstrated that AVMs occur because of errors in morphogenesis
and are composed of stable endothelial cells that do not regress
spontaneously. In addition, AVMs are associated with negative
serum b-hCG levels [16]. In our study, all of the patients in whom
uterine vascular abnormalities were diagnosed presented after a
molar pregnancy or a miscarriage; most were followed by dilation
and curettage. In our case series, all patients with vascular lesions
had an elevated serum b-hCG level; therefore, we did not use theterm AVM but instead used the terms “vascular abnormalities” and
“AVM-like lesions”. The term “malformation” is generally used to
describe defects in the structure of an organ or region of the body
resulting from an intrinsically abnormal process of development.
Therefore, the term “vascular abnormality” or “vascular lesion”
appears to best describe hypervascular areas within the uterus on
color Doppler ultrasound unless they are proved to be an AVM by
angiography or pathological examination and negative b-hCG
levels [17].
In a study of 21 AVM cases, O'Brien et al [9] suggested that a
uterine AVM diagnosis cannot be made based on gray-scale ﬁnd-
ings alone, whereas color and spectral Doppler features of uterine
AVMs are consistent and diagnostic. However, similar sonographic
pictures can be observed in patients with a positive serum b-hCG,
including those with persistently low levels of b-hCG. In these
cases, physicians should consider a diagnosis of intrauterine preg-
nancy, ectopic pregnancy, RPOC, or gestational trophoblastic
neoplasm. Kido et al [18] reported the presence of a vascular lesion
within the uterus of a patient 6 weeks after surgical pregnancy
termination. A hysterectomy was performed for a suspected AVM,
but the pathological diagnosis revealed only necrosis of the chori-
onic villi. The authors hypothesized that necrosis of the chorionic
villi left vessels with arteriovenous ﬁstulas in the retained placental
tissue. Another study described four patients with color Doppler
imaging results that were consistent with arteriovenous malfor-
mations and who exhibited elevated serum hCG levels [10]. Some
authors have reported the presence of uterine vascular lesions
following pregnancy and suggested that the condition represents
subinvolution of the placental bed [19].
In our case series, vascular abnormalities of the uterus associ-
ated with elevated serum b-hCG levels represent the subinvolution
of retained placental tissue or postmolar gestational trophoblastic
neoplasms. Although the serum b-hCG level returned to normal,
uterine vascular lesions were persistent in six cases. The vascular
lesions regressed spontaneously in ﬁve cases. In one case, the
vascular lesion regressed after uterine artery embolization and
MTX chemotherapy. In this case series, we presumed that the
persistent hCG-associated vascular abnormalities may be a pre-
cursor to future acquired AVM and that placental tissues may have
played a role in vascular disruption and neovascularization.
Consequently, we suggest that the formation of vascular lesions in
the uterus is associated with placental tissue invasion into the
myometrium in addition to its association with trauma.
In nine patients, the uterine vascular lesions disappeared after
conservative observation. The size of the vascular lesions in these
patients was less than 3 cm on color Doppler ultrasound, and serum
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After regression of the vascular lesions, b-hCG levels may be
elevated or sustained at a persistently low level. In these cases, MTX
chemotherapy or combination chemotherapy is required. Dar et al
[20] reported on the long-term follow-up of arteriovenous mal-
formations of the uterus. In four of their eight cases, sonographic
resolution of the uterine AVM occurred. Based on these results, they
suggested that conservative management should be considered as
the primary approach.
Based on our observations, we recommend checking b-hCG
levels in premenopausal womenwith vaginal bleeding. In addition,
these patients should be considered for a color Doppler ultrasound
and gray-scale transvaginal sonography. These diagnostic tools will
help to determine the uterine pathology, including vascular ab-
normalities. Moreover, three-dimensional angiography using mul-
tidetector computed tomography displays fast and clear images
that reveal the precise location of vascular lesions with their orig-
inating vessels and can help to identify suspicious vascular lesions
through color Doppler ultrasound. A uterine arteriovenous mal-
formation detected using ultrasonic and magnetic resonance im-
aging has been reported previously [21]. The authors of this
previous report suggested that ultrasound, computed tomography,
and conventional and dynamic magnetic resonance imaging (MRI)
have the advantage of being noninvasive, readily available, and
more accurately descriptive of AVM locations. Magnetic resonance
angiography should be considered as an additional tool to make a
deﬁnitive diagnosis.
When light vaginal bleeding is accompanied by decreasing
vascular lesion size and decreasing serum b-hCG levels at a weekly
follow-up, conservative management is recommended because of
the probable spontaneous disappearance of the lesions. Because
there is a possibility of sudden profuse vaginal hemorrhage during
follow-up, the patient should be referred to a center with an
interventional radiology unit. Vaginal hemorrhage occurs when the
endothelial lining of the vessels in the vascular lesion is disrupted.
Curettage can lead to heavy and even life-threatening bleeding
when the diagnosis of a vascular abnormality has not been made
prior to the intervention. In our case series, one patient underwent
an emergency hysterectomy because of profuse vaginal hemor-
rhage after an endometrial biopsy in a surgical setting. In light of
this experience, an endometrial biopsy should be performed in an
operation roomwith available anesthetic personnel and equipment
when a pathological diagnosis is needed.
If vaginal hemorrhage occurs, the uterine vascular lesion is not
decreased in size, or the serum b-hCG level is sustained or elevated,
a proper management strategy is required. When no other symp-
toms are observed, clinical follow-up should be considered because
of the possibility of spontaneous regression of the uterine vascular
lesions.
Vascular uterine abnormalities associated with pregnancy
should be considered a disease entity separate from AVMs because
of the spontaneous regression and positive serum b-hCG levels. As
mentioned previously, we presumed that acquired AVMmay follow
earlier persistent hCG-associated uterine vascular abnormalities
and that placental tissues may have been involved in vascular
disruption and neovascularization. Furthermore, the placental tis-
sue invasion into the myometrium associated with this distinct
type of abnormality may disrupt the vasculature and promote
neovascularization and therefore have long-term effects that
include the development of acquired AVM.
We recommend checking b-hCG levels in premenopausal
womenwith vaginal bleeding. In addition, these patients should be
considered for a color Doppler ultrasound and gray-scale trans-
vaginal sonography. These diagnostic tools assist in determining
the uterine pathology, including vascular abnormalities. Theprotocol developed at our institution on the basis of the published
clinical observations may be helpful in the treatment and follow-up
of vascular abnormalities (Figure 1). Further case studies are
needed to investigate the histopathological features and diagnostic
criteria for vascular abnormalities of the uterus and to establish
standard management guidelines.
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